Literature DB >> 19935663

HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.

Rasmi Thomas1, Richard Apps, Ying Qi, Xiaojiang Gao, Victoria Male, Colm O'hUigin, Geraldine O'Connor, Dongliang Ge, Jacques Fellay, Jeffrey N Martin, Joseph Margolick, James J Goedert, Susan Buchbinder, Gregory D Kirk, Maureen P Martin, Amalio Telenti, Steven G Deeks, Bruce D Walker, David Goldstein, Daniel W McVicar, Ashley Moffett, Mary Carrington.   

Abstract

A variant 35 kb upstream of the HLA-C gene (-35C/T) was previously shown to associate with HLA-C mRNA expression level and steady-state plasma HIV RNA levels. We genotyped this variant in 1,698 patients of European ancestry with HIV. Individuals with known seroconversion dates were used for disease progression analysis and those with longitudinal viral load data were used for viral load analysis. We further tested cell surface expression of HLA-C in normal donors using an HLA-C-specific antibody. We show that the -35C allele is a proxy for high HLA-C cell surface expression, and that individuals with high-expressing HLA-C alleles progress more slowly to AIDS and control viremia significantly better than individuals with low HLA-C expressing alleles. These data strongly implicate high HLA-C expression levels in more effective control of HIV-1, potentially through better antigen presentation to cytotoxic T lymphocytes or recognition and killing of infected cells by natural killer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19935663      PMCID: PMC2887091          DOI: 10.1038/ng.486

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  29 in total

1.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

Authors:  G B Cohen; R T Gandhi; D M Davis; O Mandelboim; B K Chen; J L Strominger; D Baltimore
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

Review 2.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

3.  Identifiying human MHC supertypes using bioinformatic methods.

Authors:  Irini A Doytchinova; Pingping Guan; Darren R Flower
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

4.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.

Authors:  M W Smith; M Dean; M Carrington; C Winkler; G A Huttley; D A Lomb; J J Goedert; T R O'Brien; L P Jacobson; R Kaslow; S Buchbinder; E Vittinghoff; D Vlahov; K Hoots; M W Hilgartner; S J O'Brien
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

5.  TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.

Authors:  V M Braud; D S Allan; D Wilson; A J McMichael
Journal:  Curr Biol       Date:  1998-01-01       Impact factor: 10.834

6.  Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens.

Authors:  F M Brodsky; W F Bodmer; P Parham
Journal:  Eur J Immunol       Date:  1979-07       Impact factor: 5.532

7.  A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes.

Authors:  C C Winter; E O Long
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

8.  Genetic acceleration of AIDS progression by a promoter variant of CCR5.

Authors:  M P Martin; M Dean; M W Smith; C Winkler; B Gerrard; N L Michael; B Lee; R W Doms; J Margolick; S Buchbinder; J J Goedert; T R O'Brien; M W Hilgartner; D Vlahov; S J O'Brien; M Carrington
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

9.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

10.  Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells.

Authors:  Y Shimizu; D E Geraghty; B H Koller; H T Orr; R DeMars
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

View more
  156 in total

Review 1.  Host genes important to HIV replication and evolution.

Authors:  Amalio Telenti; Welkin E Johnson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

Review 2.  Innate immune control of HIV.

Authors:  Mary Carrington; Galit Alter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Analysis of HLA-ABC locus-specific transcription in normal tissues.

Authors:  Ana Belén García-Ruano; Rosa Méndez; José María Romero; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido
Journal:  Immunogenetics       Date:  2010-09-15       Impact factor: 2.846

4.  Counteraction of HLA-C-mediated immune control of HIV-1 by Nef.

Authors:  Anke Specht; Amalio Telenti; Raquel Martinez; Jacques Fellay; Elizabeth Bailes; David T Evans; Mary Carrington; Beatrice H Hahn; David B Goldstein; Frank Kirchhoff
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

5.  Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.

Authors:  Susan E Hiby; Richard Apps; Andrew M Sharkey; Lydia E Farrell; Lucy Gardner; Arend Mulder; Frans H Claas; James J Walker; Christopher W Redman; Christopher C Redman; Linda Morgan; Clare Tower; Lesley Regan; Gudrun E Moore; Mary Carrington; Ashley Moffett
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

6.  Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.

Authors:  Hojjatollah Nozad Charoudeh; Laurent Schmied; Asensio Gonzalez; Grzegorz Terszowski; Karol Czaja; Karin Schmitter; Laura Infanti; Andreas Buser; Martin Stern
Journal:  Immunogenetics       Date:  2012-07-07       Impact factor: 2.846

7.  Correlation of Single Nucleotide Polymorphism 35-Kb Upstream of HLA-C and Clinical Profile of Multidrug-Resistant Tuberculosis.

Authors:  Umi Hani' Vismayanti Lismana; Afiono Agung Prasetyo
Journal:  J Clin Diagn Res       Date:  2015-09-01

8.  HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial.

Authors:  Heather A Prentice; Philip K Ehrenberg; Karen M Baldwin; Aviva Geretz; Charla Andrews; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; Robert J O'Connell; Merlin L Robb; Jerome H Kim; Nelson L Michael; Rasmi Thomas
Journal:  Immunogenetics       Date:  2014-03-29       Impact factor: 2.846

9.  HIV peptidome-wide association study reveals patient-specific epitope repertoires associated with HIV control.

Authors:  Jatin Arora; Paul J McLaren; Nimisha Chaturvedi; Mary Carrington; Jacques Fellay; Tobias L Lenz
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-02       Impact factor: 11.205

Review 10.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.